Back to User profile » Dr Enrico Torre
Papers published by Dr Enrico Torre:
Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective
Torre E, Di Matteo S, Martinotti C, Bruno GM, Cabrino A, Fogliati EL, Giusti A, Barbieri M, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2026, 18:585328
Published Date: 1 May 2026
Economic Evaluation of Once-Weekly Insulin Icodec from Italian NHS Perspective
Torre E, Di Matteo S, Bruno GM, Martinotti C, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2024, 16:799-811
Published Date: 6 November 2024
Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives
Torre E, Di Matteo S, Martinotti C, Bruno GM, Goglia U, Testino G, Rebora A, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2024, 16:773-784
Published Date: 24 October 2024
Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives
Torre E, Di Matteo S, Bruno GM, Martinotti C, Valentino MC, Testino G, Rebora A, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2022, 14:607-618
Published Date: 14 September 2022
Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus
Torre E, Colombo GL, Di Matteo S, Martinotti C, Valentino MC, Rebora A, Cecoli F, Monti E, Galimberti M, Di Bartolo P, Gaggioli G, Bruno GM
ClinicoEconomics and Outcomes Research 2021, 13:503-518
Published Date: 14 June 2021
Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes
Torre E, Bruno GM, Di Matteo S, Martinotti C, Oselin M, Valentino MC, Parodi A, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2018, 10:413-421
Published Date: 26 July 2018